Skip to Content

VY® Morgan Stanley Global Franchise S IVGTX

Medalist Rating as of | See Voya Investment Hub
  • NAV / 1-Day Return 16.07  /  −0.06 %
  • Total Assets 304.2 Mil
  • Adj. Expense Ratio
    1.200%
  • Expense Ratio 1.200%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Global Large-Stock Blend
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.45%
  • Turnover 14%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:18 PM GMT+0

Morningstar’s Analysis IVGTX

Will IVGTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin VY ® Morgan Stanley Global Franchise S's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IVGTX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

8.15 26.0 Mil
Technology

SAP SE

6.82 21.8 Mil
Technology

Visa Inc Class A

5.76 18.4 Mil
Financial Services

Accenture PLC Class A

5.59 17.8 Mil
Technology

Intercontinental Exchange Inc

4.32 13.8 Mil
Financial Services

RELX PLC

3.74 11.9 Mil
Industrials

UnitedHealth Group Inc

3.56 11.4 Mil
Healthcare

Thermo Fisher Scientific Inc

3.55 11.3 Mil
Healthcare

Becton Dickinson & Co

3.47 11.1 Mil
Healthcare

Aon PLC Class A

3.32 10.6 Mil
Financial Services